| 000 | 01367 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516164359.0 | ||
| 264 | 0 | _c20140714 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007995.2013.834250 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarnett, A H | |
| 245 | 0 | 0 |
_aIncreasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cNov 2013 |
||
| 300 |
_a1503-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xcomplications |
| 650 | 0 | 4 | _aDelayed Diagnosis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 |
_aRenal Insufficiency _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
| 700 | 1 | _aBrice, R | |
| 700 | 1 | _aHanif, W | |
| 700 | 1 | _aJames, J | |
| 700 | 1 | _aLangerman, H | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 29 _gno. 11 _gp. 1503-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2013.834250 _zAvailable from publisher's website |
| 999 |
_c23010487 _d23010487 |
||